-
June 28: The Week in Cancer NewsAcupuncture helps manage side effects of endocrine therapy, and adding chemotherapy before surgery delays progression in pancreatic cancer.
by Marci A. Landsmann
-
June 21: The Week in Cancer NewsRisk for cancer and cardiovascular disease linked to air pollution, and three cancer drugs could face generic competition by 2028.
by Kevin McLaughlin
-
June 14: The Week in Cancer NewsLung cancer screening linked to lower mortality in real-world data, and researchers study unusual cancer patterns after COVID-19 infection.
by Eric Fitzsimmons
-
June 7: The Week in Cancer NewsResearch supports reducing the intensity of cancer treatment, and barriers can prevent members of the LGBTQ+ community from receiving cancer screening and care.
by Thomas Celona
-
May 31: The Week in Cancer NewsYoung adults often ignore telltale signs of colorectal cancer, and more evidence supports active surveillance for low-risk prostate cancer.
by Marci A. Landsmann
-
May 24: The Week in Cancer NewsNew immunotherapy approved for small cell lung cancer, and researchers investigate using urine tests to detect cancer.
by Kevin McLaughlin
-
May 17: The Week in Cancer NewsDisparities in cancer outcomes shrink but persist, and FDA approval increases access to HPV screening.
by Eric Fitzsimmons
-
May 10: The Week in Cancer NewsPeople may be able to wait longer between colonoscopies, and a trial evaluates a less invasive option for treating prostate cancer.
by Thomas Celona
-
May 3: The Week in Cancer NewsUpdated recommendation lowers age for breast cancer screening, and laboratory tests will undergo greater FDA oversight.
by Marci A. Landsmann
-
April 26: The Week in Cancer NewsSupplemental breast screenings are not covered by Medicare, and researchers develop a treatment option for a form of eye cancer.
by Kevin McLaughlin
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
